Yahoo Web Search

Search results

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 6 days ago

      MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as Non-Executive

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 6 days ago

      MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will be

    • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 16 hours ago

      At the end of treatment, 33.3% of patients receiving imdusiran for 48 weeks, interferon (IFN) for 24 weeks and ongoing nucleoside analogue (NA) therapy achieved undetectable levels of HBsAg that were maintained in 100% of these patients 24 weeks